Voyager Therapeutics Announces Selection of Development Candidate for SOD1 Amyotrophic Lateral Sclerosis Gene Therapy Program
Source:
Nasdaq GlobeNewswire
/
06 Dec 2023 07:00:00 America/New_York
N/A
Share on,